Rezolute, Inc. financial data

Symbol
RZLT on Nasdaq
Industry
Pharmaceutical Preparations
Location
275 Shoreline Drive, Suite 500, Redwood City, CA
State of incorporation
Nevada
Fiscal year end
June 30
Former names
AntriaBio, Inc. (to 12/7/2017), FITS MY STYLE INC (to 1/11/2013)
Latest financial report
10-Q - Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.41K % -60.8%
Debt-to-equity 11.6 % +205%
Return On Equity -60.9 % -79.4%
Return On Assets -54.6 % -66.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40.1M shares +8.98%
Common Stock, Shares, Outstanding 40.1M shares +8.97%
Entity Public Float 63.6M USD +4.25%
Common Stock, Value, Issued 40K USD +8.11%
Weighted Average Number of Shares Outstanding, Basic 50.8M shares -1.16%
Weighted Average Number of Shares Outstanding, Diluted 50.8M shares -1.16%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 47.6M USD +14.8%
General and Administrative Expense 14M USD +20.5%
Operating Income (Loss) -61.6M USD -16%
Nonoperating Income (Expense) 3.35M USD -26.7%
Net Income (Loss) Attributable to Parent -58.2M USD -20.1%
Earnings Per Share, Basic -1.15 USD/shares -79.7%
Earnings Per Share, Diluted -1.15 USD/shares -64.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.93M USD -82.4%
Marketable Securities, Current 74.1M USD +6.89%
Assets, Current 82.2M USD -22.1%
Property, Plant and Equipment, Net 110K USD -26.2%
Operating Lease, Right-of-Use Asset 2.01M USD -7.64%
Assets 87.7M USD -34.6%
Accounts Payable, Current 3.5M USD +18.7%
Employee-related Liabilities, Current 879K USD
Liabilities, Current 6.96M USD +58.6%
Operating Lease, Liability, Noncurrent 1.82M USD -11.5%
Liabilities 16.9M USD +145%
Accumulated Other Comprehensive Income (Loss), Net of Tax -78K USD +40.9%
Retained Earnings (Accumulated Deficit) -306M USD -23.4%
Stockholders' Equity Attributable to Parent 70.9M USD -44.3%
Liabilities and Equity 87.7M USD -34.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.6M USD -39.5%
Net Cash Provided by (Used in) Financing Activities 11.6M USD +347%
Net Cash Provided by (Used in) Investing Activities 2.61M USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 40.1M shares +8.97%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.98M USD -304%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.93M USD -82.4%
Deferred Tax Assets, Valuation Allowance 59.2M USD +27%
Deferred Tax Assets, Gross 59.8M USD +28.3%
Operating Lease, Liability 2.37M USD -0.13%
Payments to Acquire Property, Plant, and Equipment 70K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -58.2M USD -8.07%
Lessee, Operating Lease, Liability, to be Paid 2.68M USD -8.73%
Property, Plant and Equipment, Gross 210K USD +275%
Operating Lease, Liability, Current 552K USD +73%
Lessee, Operating Lease, Liability, to be Paid, Year Two 770K USD +22.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 748K USD +8.56%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 305K USD -45.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 750K USD +16.1%
Deferred Tax Assets, Operating Loss Carryforwards 40.5M USD +5.67%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 400K shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 666K USD
Operating Lease, Payments 171K USD +490%
Additional Paid in Capital 377M USD +0.45%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 575K USD
Share-based Payment Arrangement, Expense 7.39M USD +14.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%